Sufianov, Albert,
Begliarzade, Sema,
Kudriashov, Valentin,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) of diseases and has a potential to be used as a disease marker. Oral
squamous cell carcinoma is one
Перспективы эпигенетической терапии плоскоклеточного рака головы и шеи точек,
как рецептор программируемой клеточной гибели 1 (programmed
cell death 1, PD-1) и его лиганд
Ivanova, Elizaveta,
Asadullina, Dilara,
Gilyazova, Gulshat,
Rakhimov, Radmir,
Izmailov, Adel,
Pavlov, Valentin,
Khusnutdinova, Elza,
Gilyazova, Irina (2023) renal
cell carcinoma (ccRCC) treatment. However, the response to therapy among patients
varies greatly
-deoxo- and 18,19-dehydro-GLA against conditionally normal HEK 293
cells, A549 human lung
carcinoma, MCF